BioWorld MedTech

Oct. 7, 2013

OrthoSensor in plan to market Verasense OUS

Coming off a successful approval from the FDA, OrthoSensor (Dania Beach, Florida) reported that it has received CE mark approval for its Verasense Knee System, and plans to launch the device in the European markets. Read More

Washington roundup: FDA sees 2% treatment effect from nurses in Champion trial

Report from Europe: Spire helps launch Elekta radiotherapy service in UK

Report from Asia: Unusual patent probe is seen targeting Chinese device maker

Deals roundup: Crestview Acquisition in plan to acquire GMT

Ultrasound may simplify prostate cancer screening

Restructuring roundup: Echo implements cost reduction measures

Med-Tech Notes

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...